The company notified customers that product availability will be affected by a one- to two- week lag time as the changes are processed through the distribution network, according to a Nov. 26 news release from the company.
Baxter also outlined plans to gradually increase allocations over the next several weeks, with the goal of reaching 100% allocation for several IV product codes by the end of 2024. The company has also said it will provide updates on its allocation plans in mid-December and again at year’s end.
